Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VERSUS: Solifenacin Switch Study
NCT00454740Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2004
- Primary completion
- Aug 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Jun 2004; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00454740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454740.